Literature DB >> 12941457

Very low levels of the glucocorticoid receptor beta isoform in the human hippocampus as shown by Taqman RT-PCR and immunocytochemistry.

Roel H DeRijk1, Marcel Schaaf, Floor J Stam, Inge E M de Jong, Dick F Swaab, Rivka Ravid, Erno Vreugdenhil, John A Cidlowski, E Ron de Kloet, Paul J Lucassen.   

Abstract

The hippocampus is an important target for glucocorticoid hormones. Glucocorticoid receptor (GR) mediated feedback in this area is important for control of behavioural adaptation. An alternative splice variant, the GRbeta (GRbeta) isoform, does not bind ligand and has been proposed to inhibit classic GRalpha-mediated transactivation of target genes. Hence, an increased ratio of GRbeta to GRalpha may induce relative corticosteroid-resistance, as e.g. presumed to occur in major depression. To investigate whether GRbeta is involved in the human hippocampus, we studied GRalpha and GRbeta expression levels in postmortem hippocampal tissue of control subjects by quantitative PCR (Taqman RT-PCR) and immunocytochemistry. Taqman RT-PCR demonstrated a very low relative abundance of GRbeta in the human hippocampus (GRalpha:GRbeta ratio approximately 14,500:1). Immunohistochemical analysis confirmed the occurrence of isolated profiles indeed displaying nuclear staining in the main hippocampal subregions. Subsequent double immunofluorescent analysis revealed that >98% of these GRbeta positive cells were double positive for leucocyte common antigen, that identifies exclusively blood-derived cells of haematopoietic origin, including microglia. We conclude that GRbeta is present in very low amounts in the control human hippocampus, and that of these low numbers of cells, notably, almost all are derived from blood which is inevitably present in postmortem tissue. A functionally relevant role for the GRbeta in control of the human hippocampus is therefore not very likely. Whether this is altered in disease conditions awaits further research.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941457     DOI: 10.1016/s0169-328x(03)00209-2

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  11 in total

Review 1.  Corticosteroid receptor genetic polymorphisms and stress responsivity.

Authors:  Roel DeRijk; E Ronald de Kloet
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

2.  Abnormal glucocorticoid receptor mRNA and protein isoform expression in the prefrontal cortex in psychiatric illness.

Authors:  Duncan Sinclair; Shan Yuan Tsai; Heng Giap Woon; Cynthia Shannon Weickert
Journal:  Neuropsychopharmacology       Date:  2011-08-31       Impact factor: 7.853

Review 3.  Alpha and beta glucocorticoid receptors: relevance in airway diseases.

Authors:  Laura Pujols; Joaquim Mullol; César Picado
Journal:  Curr Allergy Asthma Rep       Date:  2007-05       Impact factor: 4.806

4.  Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma.

Authors:  Elena Goleva; Ling-Bo Li; P Taylor Eves; Matthew J Strand; Richard J Martin; Donald Y M Leung
Journal:  Am J Respir Crit Care Med       Date:  2005-12-30       Impact factor: 21.405

5.  ATF2 impairs glucocorticoid receptor-mediated transactivation in human CD8+ T cells.

Authors:  Ling-bo Li; Donald Y M Leung; Matthew J Strand; Elena Goleva
Journal:  Blood       Date:  2007-05-24       Impact factor: 22.113

6.  Region-specific alterations in glucocorticoid receptor expression in the postmortem brain of teenage suicide victims.

Authors:  Ghanshyam N Pandey; Hooriyah S Rizavi; Xinguo Ren; Yogesh Dwivedi; Miklós Palkovits
Journal:  Psychoneuroendocrinology       Date:  2013-07-08       Impact factor: 4.905

7.  Cluster analysis of obesity and asthma phenotypes.

Authors:  E Rand Sutherland; Elena Goleva; Tonya S King; Erik Lehman; Allen D Stevens; Leisa P Jackson; Amanda R Stream; John V Fahy; Donald Y M Leung
Journal:  PLoS One       Date:  2012-05-11       Impact factor: 3.240

8.  Real-time PCR quantitation of glucocorticoid receptor alpha isoform.

Authors:  Murilo R Melo; Cláudia D C Faria; Keli C Melo; Nancy A Rebouças; Carlos A Longui
Journal:  BMC Mol Biol       Date:  2004-10-26       Impact factor: 2.946

9.  The Kampo Medicine Yokukansan Decreases MicroRNA-18 Expression and Recovers Glucocorticoid Receptors Protein Expression in the Hypothalamus of Stressed Mice.

Authors:  Shoko Shimizu; Takashi Tanaka; Takashi Takeda; Masaya Tohyama; Shingo Miyata
Journal:  Biomed Res Int       Date:  2015-05-14       Impact factor: 3.411

10.  Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment.

Authors:  S H Mellon; O M Wolkowitz; M D Schonemann; E S Epel; R Rosser; H B Burke; L Mahan; V I Reus; D Stamatiou; C-C Liew; S W Cole
Journal:  Transl Psychiatry       Date:  2016-05-24       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.